Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease.

P Bedossa; FLIP Pathology Consortium; Karoline Lackner

doi:10.1002/hep.27173

Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease.

P Bedossa
, FLIP Pathology Consortium
, Karoline Lackner (Collaborator)

Research output: Contribution to journal › Research article

503 Citations (Web of Science)

Original language	English
Journal	Hepatology
DOIs	https://doi.org/10.1002/hep.27173
Publication status	Published - 2014

Branches of science

301 Medical-Theoretical Sciences, Pharmacy

DOI

10.1002/hep.27173

Links

Cite this

@article{47eee169ed804afaa8f1f8f614535f35,

title = "Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease.",

author = "P Bedossa and \{FLIP Pathology Consortium\} and Karoline Lackner",

year = "2014",

doi = "10.1002/hep.27173",

language = "English",

journal = "Hepatology",

issn = "0270-9139",

publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease.

AU - Bedossa, P

AU - FLIP Pathology Consortium

A2 - Lackner, Karoline

PY - 2014

Y1 - 2014

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000339497600016

UR - https://pubmed.ncbi.nlm.nih.gov/24753132

U2 - 10.1002/hep.27173

DO - 10.1002/hep.27173

M3 - Research article

C2 - 24753132

SN - 0270-9139

JO - Hepatology

JF - Hepatology

ER -